Incidences of Deep Molecular Responses and Treatment-Free Remission in de Novo CP-CML Patients

Incidences of Deep Molecular Responses and Treatment-Free Remission in de Novo CP-CML Patients

<i>Background:</i> Tyrosine Kinase Inhibitors (TKIs) discontinuation in patients who had achieved a deep molecular response (DMR) offer now the opportunity of prolonged treatment-free remission (TFR). <i>Patients and Methods:</i> Aims of this study were to evaluate the propor...

Full description

Bibliographic Details
Main Authors: Gabriel Etienne, Stéphanie Dulucq, Fréderic Bauduer, Didier Adiko, François Lifermann, Corinne Dagada, Caroline Lenoir, Anna Schmitt, Emilie Klein, Samia Madene, Marie-Pierre Fort, Fontanet Bijou, Marius Moldovan, Beatrice Turcq, Fanny Robbesyn, Françoise Durrieu, Laura Versmée, Sandrine Katsahian, Carole Faberes, Axelle Lascaux, François-Xavier Mahon
Format: Article
Language:English
Published: MDPI AG 2020-09-01
Series:Cancers
Subjects:
chronic myeloid leukemia
tyrosine kinase inhibitor
deep molecular responses
treatment-free remission
Online Access:https://www.mdpi.com/2072-6694/12/9/2521

Internet

https://www.mdpi.com/2072-6694/12/9/2521

Similar Items